The schematic illustration of the synthesis process of Qx-D (A) and the rat model of femoral infectious bone defect (B). In the realm of orthopedic medicine, the challenge of managing infected bone ...
Our results tend to support these overall findings of reliable remodelling of DBM to new bone. The histological analysis showed significant new bone formation and decreasing residual DBM material in ...
Tumor cells are known to be fickle sleeper agents, often lying dormant in distant tissues for years before reactivating and forming metastasis. Numerous factors have been studied to understand why the ...
Tampa, FL, July 19, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc. (UATG) (“UAT Group”) announced today that its subsidiary Ossifix Orthopedics has added a new product to its ...
Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech ...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the full market release and first implants ...
SAN FRANCISCO & PARSIPPANY, N.J.--(BUSINESS WIRE)--Ossium Health®, a bioengineering company that established a first-of-its-kind bone marrow banking platform, has entered into a collaborative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback